Cautionary tales of survival analysis: Conflicting analyses from a clinical trial in breast cancer

British Journal of Cancer

Volumn 76, Issue 4, 1997, Pages 551-558

  Gregory, W M ^a   Bolland, K ^b   Whitehead, J ^b   Souhami, R L ^c  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Proportional hazards; Randomized trial; Survival analysis

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0030760714     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.424     Document Type: Article

References (16)

1. Collett D (1994) Modelling Survival Data in Medical Research. Chapman & Hall: London
2. Cox DR (1972) Regression models and life-tables. J R Statist Soc B34: 187-202
3. Fayers PM, Cooke PA, Machin D, Donaldson N, Whitehead J, Ritchie A, Oliver RTD, Members of the Urolological Working Party Renal Carcinoma Subgroup and Yuen P (1994) On the development of the Medical Research Council trial of α-Interferon in metastatic renal carcinoma. Stats Med 13: 2249-2260
4. Freedman LS (1982) Tables of the number of patients required in clinical trials using the logrank test. Stats Med 1: 121-129
5. Gould AL (1992) Interim analysis for monitoring clinical trials that do not materially affect the type I error rate. Stats Med 11: 55-66
6. Kalbfleisch JD and Prentice RL (1981) Estimation of the average hazard ratio. Biometrika 68: 105-112
7. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. Am Stat Assoc J 53: 457-481
8. Machin D and Campbell MJ (1987) Statistical Tables for the Design of Clinical Trials. Blackwell Scientific Publications: Oxford
9. Parmar MKB and Machin D (1995) Survival Analysis: A Practical Approach. Wiley: Chichester
10. Pepe MS and Fleming TR (1989) Weighted Kaplan-Meier statistics: a class of distance tests for censored survival data. Biometrics 45: 497-507
11. Peto R and Peto J (1972) Asymptotically efficient rank invariant test procedures (with discussion). J R Stat Soc Series A 135: 185-206
12. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J and Smith PG (1977) Design and analysis of randomised clinical trials requiring prolonged observations of each patient. II. Analysis and examples. Br J Cancer 35: 1-39
13. Rubens RD, Bartelink H, Engelsman E, Hayward JL, Rotmensz N, Sylvester R, Van Der Scheuren E, Papadiamantis J, Vasskaros SD, Wildiers J and Winter PJ (1989) Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792). Eur J Cancer Clin Oncol 25: 667-678
14. Souhami R (1994) The clinical importance of early stopping of randomised trials in cancer treatments. Stats Med 13: 1293-1295
15. Sylvester R, Bartelink H and Rubens R (1994) A reversal of fortune: practical problems in the monitoring and interpretation of an EORTC breast cancer trial. Stats Med 13: 1329-1335
16. Whitehead J (1993) Interim analyses and stopping rules in cancer clinical trials. Br J Cancer 68: 1179-1185